Drug Trial Radar · NCT07647510
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
195
Planned (sponsor's estimate)
Start
Jun 29, 2026
Primary completion
Dec 2028
Study completion Sep 2031
Sponsor
- Lead sponsor
- Dianthus TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 15, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase 3 study is to demonstrate the efficacy, safety, and tolerability of claseprubart in participants with generalized myasthenia gravis (gMG).
Conditions
- Myasthenia Gravis, Generalized
Interventions
ClaseprubartDrug
IV loading dose on Day 1
PlaceboDrug
IV infusion on Day 1
ClaseprubartCombination product
Prefilled syringe containing claseprubart for SC administration
PlaceboCombination product
Prefilled syringe containing placebo for SC administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline to Week 17 in Myasthenia Gravis Activities of Daily Living (MG-ADL) Scale ScoreTime frame: Baseline (Day 1) to Week 17
Locations
12 sites in 3 countries. Site status is shown where the registry gives one.
Clinical Study Site
Pasadena, California · Recruiting
Cinical Study Site
Boca Raton, Florida · Recruiting
Cinical Study Site
Fayetteville, North Carolina · Not yet recruiting
Cinical Study Site
Houston, Texas · Recruiting
Cinical Study Site
Kutaisi, Georgia · Recruiting
Clinical Study Site #2
Tbilisi, Georgia · Recruiting
Clinical Study Site #3
Tbilisi, Georgia · Recruiting
Clinical Study Site #4
Tbilisi, Georgia · Recruiting
Clinical Study Site #5
Tbilisi, Georgia · Recruiting
Clinical Study Site
Tbilisi, Georgia · Recruiting
Cinical Study Site
Dnipro, Ukraine · Recruiting
Cinical Study Site
Vinnytsia, Ukraine · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.